Cardiovascular failure | Respiratory failure | p-value | |
---|---|---|---|
Population characteristics | |||
Number of patients | 129 (54.7%) | 107 (45.3%) | – |
Age (years) | 68 ± 16 | 57 ± 17 | < 0.0001 |
Males, n (%) | 85 (65.9%) | 65 (60.7%) | 0.4097 |
BSA (m2) | 1.84 ± 0.20 | 1.89 ± 0.24 | 0.1339 |
APACHE II | 13.3 ± 5.8 | 12.5 ± 3.8 | 0.2460 |
Ventilation and gas exchanges | |||
Mechanical ventilation (included NIV), n | 100 (77.5%) | 104 (92.5%) | 0.0017 |
PEEP (cmH2O) | 8.0 (6.0–10.0) | 10.0 (8.0–12.0) | 0.0001 |
PaO2/FiO2 (mmHg) | 211.5 (179.0–235.0) | 168.0 (115.3–194.8) | < 0.0001 |
PaCO2 (mmHg) | 40.0 (36.0–45.0) | 49.0 (43.0–57.0) | < 0.0001 |
Echocardiographic parameters and derived variables | |||
TAPSE (mm) | 12.0 (8.4–18.2) | 20.0 (15.2–23.7) | < 0.0001 |
S’ (cm/s) | 7.6 (4.7–11.6) | 10.2 (8.2–14.5) | 0.001 |
RAP (mmHg) | 10.0 (8.0–10.0) | 8.0 (8.0–10.0) | 0.4751 |
sPAP (mmHg) | 44.0 (38.3–51.9) | 52.9 (43.9–63.1) | < 0.0001 |
PAAT (ms) | 85.0 (71.0–95.0) | 92.0 (77.0–103.0) | 0.0056 |
Log10PAAT | 1.93 (1.85–1.98) | 1.96 (1.89–2.01) | 0.0057 |
HR (bpm) | 90 (80–102) | 76 (61–89) | < 0.0001 |
RVET (ms) | 234.5 (202.5–266.0) | 221.0 (189.5–265.8) | 0.0552 |
PAAT/√RR | 3.18 (2.79–3.73) | 3.20 (2.59–3.77) | 0.5399 |
PAAT/RVET | 0.36 (0.29–0.41) | 0.41 (0.34–0.50) | 0.0001 |